Khalili Leila, Park Gwoncheol, Nagpal Ravinder, Bhide Pradeep, Salazar Gloria
Department of Health, Nutrition, and Food Sciences, Florida State University, Tallahassee, FL 32306, USA.
Institute for Pediatric Rare Diseases and Department of Biomedical Sciences, Florida State University, College of Medicine, Tallahassee, FL 32306, USA.
Curr Neuropharmacol. 2025 Mar 18. doi: 10.2174/011570159X360149250225041829.
Akkermansia muciniphila (A. muciniphila), a bacterial species within the human gut microbiome, has shown beneficial effects on host health. Emerging research suggests that A. muciniphila also influences neurobehavioral domains through the microbiota-gut-brain axis. This meta-analysis evaluates A. muciniphila's impact on depression, anxiety, and stress in mouse models.
We conducted a systematic search of PubMed, Science Direct, Embase, and Web of Science databases up to March 2024, identifying 15 eligible studies.
Supplementation with A. muciniphila, its outer membrane protein (Amuc_1100), and extracellular vesicles (EVs) alleviated anxiety, depressive-like behaviors, and enhanced memory in mice. Compared to controls, intervention groups exhibited reduced anxiety-like behaviors, including increased travel distance in the open-field test (OFT) and more time spent in the lightbox during the light-dark box (LDB) test and open arms in the elevated plus maze (EPM). Depression-like symptoms were reduced, with lower immobility time in the tail suspension and forced swim tests. Memory function also improved, and learning time was reduced in the Y-maze and Barnes circular maze tests. Serotonin levels increased significantly in the serum and hippocampus, while corticosterone levels decreased, though not significantly. The intervention reduced hippocampal and serum inflammatory markers (TNFα, IL1β, IL6) and altered gut microbiome composition, increasing Akkermansia, Roseburia, Caldicoprobacter, and Lachnospiraceae.
This meta-analysis provides evidence supporting the health-promoting effects of A. muciniphila, one of the next-generation probiotics, in alleviating neuropsychiatric disorders. Given the high prevalence and clinical significance of depression, anxiety, and stress, further investigation into the therapeutic utility of A. muciniphila is warranted.
嗜黏蛋白阿克曼氏菌(A. muciniphila)是人类肠道微生物群中的一种细菌,已显示出对宿主健康有益的作用。新出现的研究表明,嗜黏蛋白阿克曼氏菌还通过微生物-肠道-脑轴影响神经行为领域。本荟萃分析评估了嗜黏蛋白阿克曼氏菌对小鼠模型中抑郁、焦虑和应激的影响。
我们对截至2024年3月的PubMed、Science Direct、Embase和Web of Science数据库进行了系统检索,确定了15项符合条件的研究。
补充嗜黏蛋白阿克曼氏菌、其外膜蛋白(Amuc_1100)和细胞外囊泡(EVs)可减轻小鼠的焦虑、抑郁样行为并增强记忆力。与对照组相比,干预组表现出焦虑样行为减少,包括旷场试验(OFT)中行进距离增加、明暗箱试验(LDB)中在亮箱中停留时间延长以及高架十字迷宫试验(EPM)中在开放臂停留时间延长。抑郁样症状减轻,在悬尾试验和强迫游泳试验中不动时间减少。记忆功能也得到改善,在Y迷宫试验和巴恩斯圆形迷宫试验中学习时间缩短。血清和海马中的血清素水平显著升高,而皮质酮水平虽有下降但不显著。干预降低了海马和血清中的炎症标志物(TNFα、IL1β、IL6),并改变了肠道微生物群组成,增加了嗜黏蛋白阿克曼氏菌、罗斯氏菌属、嗜热栖热放线菌和毛螺菌科。
本荟萃分析提供了证据,支持下一代益生菌之一的嗜黏蛋白阿克曼氏菌在减轻神经精神疾病方面的健康促进作用。鉴于抑郁、焦虑和应激的高患病率及临床意义,有必要进一步研究嗜黏蛋白阿克曼氏菌的治疗效用。